CONMED Corporation (CNMD)

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Super investor ownership

12 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

• Capital Research Global, Capital Research Global Investors$26.96M · 0.0% of book
• Two Sigma, TWO SIGMA INVESTMENTS, LP$23.86M · 0.0% of book
• Arrowstreet Capital, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$15.61M · 0.0% of book
• Cliff Asness, AQR CAPITAL MANAGEMENT LLC$9.19M · 0.0% of book
• Marshall Wace, MARSHALL WACE, LLP$5.74M · 0.0% of book

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in CNMD

Trades in CNMD disclosed by members of Congress and executive-branch officials, latest first:

• Donald J Trump · Executive branchSell · $15,001 - $50,000 · traded 30 Apr 2026 · disclosed 1 Jul 2026
• Donald J Trump · Executive branchSell · $15,001 - $50,000 · traded 8 Jul 2024 · disclosed 22 Sept 2026
• Donald J Trump · Executive branchBuy · $15,001 - $50,000 · traded 4 Jun 2024 · disclosed 22 Aug 2026

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

Common questions